A review of oxycodone's clinical pharmacokinetics and pharmacodynamics.

[1]  E. Kalso,et al.  The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. , 1992, British journal of clinical pharmacology.

[2]  E. Kalso,et al.  Pharmacodynamic interactions of oxycodone and amitriptyline in healthy volunteers , 1992 .

[3]  E. Kalso,et al.  Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats. , 1992, Pharmacology & toxicology.

[4]  E. Kalso,et al.  Intravenous morphine and oxycodone for pain after abdominal surgery , 1991, Acta anaesthesiologica Scandinavica.

[5]  E. Kalso,et al.  The pharmacokinetics of oxycodone after intravenous injection in adults. , 1991, British journal of clinical pharmacology.

[6]  J. Tien.  Transdermal-controlled administration of oxycodone. , 1991, Journal of pharmaceutical sciences.

[7]  E. Kalso,et al.  Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. , 1990, Pharmacology & toxicology.

[8]  E. Kalso,et al.  Morphine and oxycodone hydrochloride in the management of cancer pain , 1990, Clinical pharmacology and therapeutics.

[9]  J. Plummer,et al.  Influence of polarity on dose-response relationships of intrathecal opioids in rats , 1990, Pain.

[10]  M. Mattila,et al.  Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers. , 1989, Pharmacology & toxicology.

[11]  K. Foley,et al.  Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.

[12]  P. Hoskin,et al.  Opioid therapy in malignant disease , 1987 .

[13]  P. Hoskin,et al.  Review article : Opioid analgesics in the management of pain in patients with cancer. A review , 1987 .

[14]  E. Wuolijoki,et al.  Diclofenac and oxycodone in treatment of postoperative pain: a double‐blind trial , 1986, Acta anaesthesiologica Scandinavica.

[15]  D. W. Swanson,et al.  Problems with the use of oxycodone compound in patients with chronic pain , 1981, PAIN®.

[16]  K. Korttila,et al.  Comparison of i.m. lysine acetylsalicylate and oxycodone in the treatment of pain after operation. , 1980, British journal of anaesthesia.

[17]  J. Gaylord,et al.  Determination of oxycodone in plasma and identification of a major metabolite. , 1979, Journal of pharmaceutical sciences.

[18]  R. Houde,et al.  Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. , 1978, The Journal of pharmacology and experimental therapeutics.

[19]  R. Houde,et al.  Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. , 1978, The Journal of pharmacology and experimental therapeutics.

[20]  T. Tammisto,et al.  A comparison of pethidine, piritramide and oxycodone in patients with pain following cholecystectomy. , 1973, Der Anaesthesist.

[21]  A. Somogyi,et al.  Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.

[22]  Twycross Rg.  Opioid analgesics in cancer pain: current practice and controversies. , 1988 .

[23]  Randall C. Baselt,et al.  Disposition of toxic drugs and chemicals in man , 1982 .

[24]  H. Halbach,et al.  Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances. , 1956, Bulletin of the World Health Organization.